[Current developments in Helicobacter pylori therapy].
Labenz
J
J
Medizinische Klinik, Elisabeth-Krankenhaus Essen.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004415:Dyspepsia / Q000188:drug therapy*; D005756:Gastritis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D013276:Stomach Ulcer / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D017291:Clarithromycin
Aktuelle Entwicklungen der Helicobacter pylori-Therapie.